|
|
|
40
|
05743
|
ENDOXAN 50MG TAB (BAX/STO) CYCLOPHOSPHAMIDE
|
CYCLOPHOSPHAMIDE
|
ENDOXAN
|
50'S
|
B
|
0.95
|
0.02
|
TABLET
|
0
|
TAB
|
BAX
|
BAXTER EXPORT CORP.
|
STO
|
BRYDEN STOKES LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
05743
|
ENDOXAN 50MG TAB (BAX) CYCLOPHOSPHAMIDE
|
CYCLOPHOSPHAMIDE
|
ENDOXAN
|
50'S
|
A
|
1.33
|
0.0266
|
TAB
|
240
|
BOX
|
BAX
|
BAXTER EXPORT CORP.
|
STO
|
BRYDEN STOKES LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
05752
|
ENDOXAN 1G INJ (ASM/COL) CYCLOPHOSPHAMIDE
|
CYCLOPHOSPHAMIDE
|
ENDOXAN
|
1G VIAL
|
BQ
|
38.06
|
38.06
|
INJECTION
|
0
|
VIAL
|
ASM
|
ASTA MEDICA AG
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
05756
|
ENDOXAN 1G INJ (BAX/STO) CYCLOPHOSPHAMIDE
|
CYCLOPHOSPHAMIDE
|
ENDOXAN
|
1G VIAL
|
BQ
|
15.96
|
15.96
|
INJECTION
|
0
|
VIAL
|
BAX
|
BAXTER EXPORT CORP.
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
05756
|
ENDOXAN 1G INJ (BAX) CYCLOPHOSPHAMIDE (BQ)
|
CYCLOPHOSPHAMIDE
|
ENDOXAN
|
1G VIAL
|
BQ
|
17.34
|
17.3429
|
VIAL
|
30
|
VIAL
|
BAX
|
BAXTER EXPORT CORP.
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
0575F
|
CYCLOPHOSPHAMIDE 1G INJ (KWA) (BQ)
|
CYCLOPHOSPHAMIDE
|
CYCLOPHOSPHAMIDE
|
1G VIAL
|
BQ
|
10.41
|
10.4112
|
VIAL
|
30
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
ANTINEOPLASTICS
|
|